Some achievements of CANTAM2:
- The training capacity platform was expanded to 12 institutions with 5 african countries and 3 european partners.
- Clinical research capacities on TB/HIV and NTDs were strengthened,, and the first multicenter clinical trial on malaria was successfully conducted (ClinicalTrials.gov)
- The capacity building of the National Regulatory Authorities (NRAs) also initiated with the establishment of collaboration with the NRAs of Central Africa and the activation of pharmacovigilance activities in countries whereby, Congo became a member of the Who international pharmacovigilance system in November 2020.
- More than 20 young researcher developed their capacities during this phase 2 of CANTAM.
- A series of workshops on topics of interest (CRISPR-Cas 9 gene editing, 3D printing, grant writing and scientific writing sessions) brought together researchers from the sub-region.
- Gender aspect was addressed in schools with awareness campaigns with priortity given to any female candidates and award of excellence to the best female scientist in Congo to encourage young scientists.
- With the outbreak of COVID-19, the network researchers were flag bearers in scientific committees in their respective nations; by participating in the diagnosis and resolution of important research questions during the crisis.
- The 3D lab manufactured an artificial respirator and protective visors for patient care centers in the country and more.